IDEXX Laboratories (IDXX) is a publicly traded Healthcare sector company. As of May 20, 2026, IDXX trades at $551.48 with a market cap of $43.05B and a P/E ratio of 40.37. IDXX moved +1.27% today. Year to date, IDXX is -18.86%; over the trailing twelve months it is +7.04%. Its 52-week range spans $356.14 to $769.98. Analyst consensus is buy with an average price target of $693.17. Rallies surfaces IDXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IDXX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IDXX recently traded at $551.48. Market cap is $43.05B. P/E ratio is 40.37. Revenue is $4.45B.
| Metric | Value |
|---|---|
| Price | $551.48 |
| Market Cap | $43.05B |
| P/E Ratio | 40.37 |
| EPS | $13.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $769.98 |
| 52-Week Low | $356.14 |
| Volume | 435.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.45B |
| Net Income | $1.10B |
| Gross Margin | 62.05% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $4.30B | $1.06B | $13.17 |
| 2024 | $3.90B | $887.87M | $10.77 |
| 2023 | $3.66B | $845.04M | $10.17 |
| 2022 | $3.37B | $679.09M | $8.12 |
7 analysts cover IDXX: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $693.17.